Unknown

Dataset Information

0

Rational design, synthesis, molecular modeling, biological activity, and mechanism of action of polypharmacological norfloxacin hydroxamic acid derivatives.


ABSTRACT: Fluoroquinolones are broad-spectrum antibiotics that target gyrase and topoisomerase IV, involved in DNA compaction and segregation. We synthesized 28 novel norfloxacin hydroxamic acid derivatives with additional metal-chelating and hydrophobic pharmacophores, designed to enable interactions with additional drug targets. Several compounds showed equal or better activity than norfloxacin against Gram-positive, Gram-negative, and mycobacteria, with MICs as low as 0.18 μM. The most interesting derivatives were selected for in silico, in vitro, and in vivo mode of action studies. Molecular docking, enzyme inhibition, and bacterial cytological profiling confirmed inhibition of gyrase and topoisomerase IV for all except two tested derivatives (10f and 11f). Further phenotypic analysis revealed polypharmacological effects on peptidoglycan synthesis for four derivatives (16a, 17a, 17b, 20b). Interestingly, compounds 17a, 17b, and 20b, showed never seen before effects on cell wall synthetic enzymes, including MreB, MurG, and PonA, suggesting a novel mechanism of action, possibly impairing the lipid II cycle.

SUBMITTER: Kamal El-Sagheir AM 

PROVIDER: S-EPMC10718593 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rational design, synthesis, molecular modeling, biological activity, and mechanism of action of polypharmacological norfloxacin hydroxamic acid derivatives.

Kamal El-Sagheir Ahmed M AM   Abdelmesseh Nekhala Ireny I   Abd El-Gaber Mohammed K MK   Aboraia Ahmed S AS   Persson Jonatan J   Schäfer Ann-Britt AB   Wenzel Michaela M   Omar Farghaly A FA  

RSC medicinal chemistry 20230919 12


Fluoroquinolones are broad-spectrum antibiotics that target gyrase and topoisomerase IV, involved in DNA compaction and segregation. We synthesized 28 novel norfloxacin hydroxamic acid derivatives with additional metal-chelating and hydrophobic pharmacophores, designed to enable interactions with additional drug targets. Several compounds showed equal or better activity than norfloxacin against Gram-positive, Gram-negative, and mycobacteria, with MICs as low as 0.18 μM. The most interesting deri  ...[more]

Similar Datasets

| S-EPMC10653056 | biostudies-literature
| S-EPMC9324959 | biostudies-literature
| S-EPMC2602756 | biostudies-literature
| S-EPMC9069940 | biostudies-literature
| S-EPMC9315260 | biostudies-literature
| S-EPMC11536644 | biostudies-literature
| S-EPMC7464486 | biostudies-literature
| S-EPMC10059083 | biostudies-literature
| S-EPMC11013662 | biostudies-literature
| S-EPMC6278332 | biostudies-literature